Results 151 to 160 of about 10,402 (207)

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study. [PDF]

Br J Cancer
Yap TA, LoRusso P, Miller RE, Kristeleit R, Paulovich AG, McMorn S, Oplustil O'Connor L, Lombardi B, Marco-Casanova P, Gangl ET, Patel B, O'Connor MJ, Dean E, Zviezdin R, Plummer R.   +14 more
europepmc   +1 more source

Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis. [PDF]

Int J Gynecol Cancer
Steinlechner M, Strobel L, Leitner K, Pan TL, Feroz B, Marth C, Zeimet AG.   +6 more
europepmc   +1 more source

Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. [PDF]

Mol Pharm
Li Y, Ettah U, Jacques S, Gaikwad H, Monte A, Dylla L, Guntupalli S, Moghimi SM, Simberg D.   +8 more
europepmc   +1 more source

Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy. [PDF]

Am J Kidney Dis
Glezerman I, Salvatore S, Tap W, Kelly C, Brauer Ornelas CM, Shaikh A.   +5 more
europepmc   +1 more source

Comparison of Hepatic Function and Chemotherapy-Induced Side Effects Between Pegylated Liposomal Doxorubicin (PLD), Topotecan (TOPO), and Gemcitabine in Platinum-Resistant Ovarian Cancer (PROC). [PDF]

J Pers Med
Dragomir RD, Mercioni MA, Negru Ș, Popovici D, Săftescu S, Blidari AR, Sas I.   +6 more
europepmc   +1 more source

Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results. [PDF]

Oncologist
Xia ZG, Lv FF, Zhang QL, Liu YZ, Zhang SJ, Liu C, Li XQ, Wen Y, Wu ZY, Hong XN, Guo Y, Cao JN.   +11 more
europepmc   +1 more source

Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin. [PDF]

Acta Pharmacol Sin
Yu YF, Wu EC, Lin SQ, Chu YX, Yang Y, Pan F, Ding TH, Qian J, Jiang K, Zhan CY.   +9 more
europepmc   +1 more source

Bortezomib/Dexamethasone/Pegylated Liposomal Doxorubicin Regimen [PDF]

, 2020
openaire   +1 more source

Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study. [PDF]

Technol Cancer Res Treat
Luo B, Tan X, Zhang Y, Hu X, Zeng H, Xiao H, Lou S, Zhou K.   +7 more
europepmc   +1 more source